Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Takenori Ichimura"'
Publikováno v:
Clinical Case Reports, Vol 11, Iss 5, Pp n/a-n/a (2023)
Key Clinical Message A 49‐year‐old female with non‐small‐cell lung cancer was placed on adjuvant chemotherapy with vinorelbine (25 mg/m2: Day 1.8) and cisplatin (80 mg/m2: Day 1). The simultaneous intravenous infusion of vinorelbine from the
Externí odkaz:
https://doaj.org/article/2c9872cd06cf46d98c40a06319b3a9e6
Publikováno v:
SAGE Open Medicine, Vol 11 (2023)
Objectives: Many patients with hormone-receptor positive breast cancer undergo prolonged treatment. However, the long-term patient quality of life assessment has not been examined. Using community pharmacists’ assistance is one method for assessing
Externí odkaz:
https://doaj.org/article/0b2a27f2905e4ed9a05222c97fa92fad
Publikováno v:
SAGE Open Medical Case Reports, Vol 11 (2023)
Atezolizumab plus bevacizumab is the recommended first-line treatment for unresectable hepatocellular carcinoma, based on guidelines from the Barcelona Clinic Liver Cancer prognosis and treatment strategy. However, atezolizumab plus bevacizumab may b
Externí odkaz:
https://doaj.org/article/7a65bc3b0473407bbc9b1f049b14674b
Publikováno v:
SAGE Open Medical Case Reports, Vol 9 (2021)
There are few reports on the effectiveness of corticosteroids for immune checkpoint inhibitor-induced interstitial pneumonia in patients with a history of interstitial pneumonia. We report on 10 non-small cell lung cancer patients with a history of i
Externí odkaz:
https://doaj.org/article/c81ead8ddb494a148519f8386a167d74
Autor:
Satoshi Yuge, Ryota Tsukioka, Katsuaki Miyahara, Kenichi Suzuki, Takenori Ichimura, Hisanori Shimizu, Tomonobu Yoshimura, Hayato Murata, Keisuke Kado, Chiaki Ogawa, Hisanaga Nomura
Publikováno v:
Die Pharmazie. 77(6)
Background: Patients who develop severe side-effects when taking high-risk drugs may have a significantly reduced health-related quality of life (QOL); therefore, it is important to identify changes in health-related QOL in these patients. This study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb58c591212db71b0e95ff7ed50d1334
https://pubmed.ncbi.nlm.nih.gov/35751159
https://pubmed.ncbi.nlm.nih.gov/35751159
Autor:
Takenori Ichimura
Publikováno v:
Journal of Oncology Pharmacy Practice. :107815522311652
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8b9cd75511909fc550c8b310156f70b3
https://doi.org/10.1177/10781552231165235
https://doi.org/10.1177/10781552231165235
Autor:
Kaoru Murakami, Atsuko Minemura, Tadanori Sasaki, Takenori Ichimura, Masahiro Usuda, Daisuke Ichikura, Shuichi Nawata, Wataru Kawashima
Publikováno v:
YAKUGAKU ZASSHI. 140:929-936
Cisplatin therapy induces kidney injury as a side effect. Thus, replacement fluid must be administered to prevent kidney injury. In our hospital, we use a Gemcitabine and Cisplatin combination chemotherapy (GC) at a total volume of approximately 500
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ceb9f82d5555aa23c3bb625dd4ca82b
https://doi.org/10.1248/yakushi.19-00223
https://doi.org/10.1248/yakushi.19-00223
Publikováno v:
Cancer Chemotherapy and Pharmacology
Purpose The immune checkpoint inhibitor nivolumab is commonly used for non-small-cell lung cancer treatment. Immune checkpoint inhibitors cause immune-related adverse events, including interstitial pneumonia. However, there are no studies on the risk
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7170beb702338790446ec1b262b9e80
https://pubmed.ncbi.nlm.nih.gov/34648059
https://pubmed.ncbi.nlm.nih.gov/34648059
Publikováno v:
SAGE Open Medical Case Reports, Vol 9 (2021)
SAGE Open Medical Case Reports
SAGE Open Medical Case Reports
There are few reports on the effectiveness of corticosteroids for immune checkpoint inhibitor-induced interstitial pneumonia in patients with a history of interstitial pneumonia. We report on 10 non-small cell lung cancer patients with a history of i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cdb45d88b3b16b629ad538efdb74ebc2
https://doaj.org/article/c81ead8ddb494a148519f8386a167d74
https://doaj.org/article/c81ead8ddb494a148519f8386a167d74